Icaritin has been tested in a cell model with mutations in TDP-43, another gene implicated in ALS, and its protective effect, specifically the mitigation of mitochondrial damage and the reduction in oxidative stress, has been validated [149]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.